This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.
MonumenTAL-6 randomized first-relapse/early R/R patients to talquetamab+teclistamab, talquetamab+pomalidomide, or standard elotuzumab/daratumumab+pomalidomide+dexamethasone comparators expected to ...
All notable changes to this project are documented in this file. The format is based on Keep a Changelog 1.1.0, and this project adheres to Semantic Versioning 2.0.0. STEP-08 D6: docs/POSITIONING.md, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results